7710-42-1

Basic information

• Product Name: 1,3,5-Triazine-2,4,6-triamine, N,N-dimethyl-N',N''-diphenyl-
• CAS NO: 7710-42-1
• Molecular Formula: C17H18N6
• Molecular Weight: 306.37
• Mol File: 7710-42-1.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 1,3,5-Triazine-2,4,6-triamine, N,N-dimethyl-N',N''-diphenyl-(CAS DataBase Reference)
• NIST Chemistry Reference: 1,3,5-Triazine-2,4,6-triamine, N,N-dimethyl-N',N''-diphenyl-(7710-42-1)
• EPA Substance Registry System: 1,3,5-Triazine-2,4,6-triamine, N,N-dimethyl-N',N''-diphenyl-(7710-42-1)

Safety Data

• Hazardous Substances Data: 7710-42-1(Hazardous Substances Data)

Upstream product

• 1973-09-7 6-chloro-N,N'-diphenyl-1,3,5-triazine-2,4-diamine 
• 124-40-3 dimethyl amine 
• 68-12-2 N,N-dimethyl-formamide 
• 75-31-0 isopropylamine 
• 2272-40-4 2-phenylamino-4,6-dichloro-s-triazine 
• 62-53-3 aniline 

Relevant articles and documents

Heterocyclic IDH mutant inhibitor, preparation method and application thereof

The invention discloses a heterocyclic IDH mutant inhibitor, a preparation method and application thereof, belongs to the field of medicines, and particularly relates to a s-triazine compound with structural characteristics of a general formula (I) or a pharmaceutically acceptable salt thereof, a pharmaceutical composition, a preparation method of the s-triazine compound, and application of the s-triazine compound or the pharmaceutically acceptable salt and the pharmaceutical composition as isocitrate dehydrogenase 2 (IDH2) mutant inhibitors. The compound disclosed by the invention has an obvious inhibiting effect on the activity of an IDH2 mutant (mIDH2), can effectively inhibit the process of catalyzing alpha-ketoglutaric acid to generate 2-hydroxyglutaric acid by the mIDH2, and can be used for preventing and/or treating various related diseases including cancers caused by IDH2 mutation.